TriSalus Life Sciences is a biopharma company that specializes in treatment research and development for tumors of the liver and pancreas. TriSalus involves a team of clinicians and scientists who develop systemic immunotherapies to fight tumors through its developed drug delivery methods.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
10/5/2022 | Series B-2 |
$15.32MM raised | $XXX.XX | $XXX.XX |
9/29/2021 | Series B-1 and B-3 |
$40.64MM raised | $XXX.XX | $XXX.XX |
3/18/2021 | Series B |
$85.22MM raised | $XXX.XX | $XXX.XX |
3/2/2017 | Series A-6 |
$16.3MM raised | $XXX.XX | $XXX.XX |
12/2/2015 | Series A-4 and A-5 |
$15.12MM raised | $XXX.XX | $XXX.XX |
11/7/2013 | Series A-2 and A-3 |
$19.68MM raised | $XXX.XX | $XXX.XX |
7/6/2011 | Series A-1 |
$6.53MM raised | $XXX.XX | $XXX.XX |